Literature DB >> 2354519

Coronary artery aneurysm formation following percutaneous transluminal coronary angioplasty: treatment of associated restenosis with repeat percutaneous transluminal coronary angioplasty.

G D Walford1, M G Midei, T R Aversano, S O Gottlieb, P H Chew, J A Brinker.   

Abstract

Restenosis following coronary angioplasty can usually be treated effectively and safely by repeated angioplasty. However, the presence of a complex lesion morphology may bias the clinician away from angioplasty toward either recommending bypass surgery or continuing medical therapy alone in spite of recurrence of the symptoms which were sufficient indication for the initial angioplasty. One type of complex morphology at the site of the restenosis is due to the presence of a focal, eccentric aneurysmal dilatation similar in appearance to a saccular aneurysm. In two previously reported cases in the literature both were referred to bypass surgery. We report eight additional cases including the use of repeat successful angioplasty in six of the cases in spite of the potential problems posed by the complexity of the restenosed lesion. In addition, this case review suggests that this type of complex lesion morphology with restenosis may be more common when the initial angioplasty was associated with deep arterial injury, as in patients whose initial angioplasty was done in an infarct-related vessel or was associated with evidence of a large dissection.

Entities:  

Mesh:

Year:  1990        PMID: 2354519     DOI: 10.1002/ccd.1810200203

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  2 in total

1.  Coronary Aneurysm: An Enigma Wrapped in a Mystery.

Authors:  Davide Carino; Arvind Agarwal; Mrinal Singh; Judith Meadows; Bulat A Ziganshin; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2019-10-15

2.  Cytokine Disturbances in Coronary Artery Ectasia Do Not Support Atherosclerosis Pathogenesis.

Authors:  Usama Boles; Anders Johansson; Urban Wiklund; Zain Sharif; Santhosh David; Siobhan McGrory; Michael Y Henein
Journal:  Int J Mol Sci       Date:  2018-01-16       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.